
Overview
Because Access is Everything
Even the most sophisticated, cutting-edge medical diagnostics aren’t of value unless we can get them to those who need them most. At Access Bio, we believe every life is precious, and every human on earth deserves the opportunity to live a healthy life, free from the threat of infectious diseases.
Access Bio is dedicated to the prevention and early diagnosis of infectious diseases through research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. Based on the greatest needs and the potential to do the most good, we work with partners across the world, including the Bill and Melinda Gates Foundation, the World Health Organization, Doctors Without Borders, UNICEF, and many others.
Vision
Our Vision and Strategy
A Sustainable Business Based on Innovation, Value, and Global Good

Vision
Our Vision and Strategy
A Sustainable Business Based on Innovation, Value, and Global Good

Global pioneer in invitro diagnostic technologies

Promote health and well-being of mankind via accurate diagnosis of diseases


Reinforce market
presence and
diversify markets
Reinforce market footing
in malaria diagnosis;
launch new diagnostic
products including tests
for COVID-19, G6PD
deficiency, dengue fever,
influenza, and strep A
Strengthen quality
control and customer
relationships
Maintain stringent quality
control; strengthen
relationships with customers
including international
agencies, non-profit
organizations, and retailers.
Develop
value-added
products
Build a portfolio of
value-added products
based on cutting-edge
technologies in in vitro
diagnostics.
Enhance
sustainability
of profits
Reduce costs via product
diversification, economies
of scale, and production
automation.
Vision
Our Vision and Strategy
A Sustainable Business Based on Innovation, Value, and Global Good

Global pioneer in invitro diagnostic technologies

Promote health and well-being of mankind via accurate diagnosis of diseases


Reinforce market presence and diversify markets
Reinforce market footing in malaria diagnosis; launch new diagnostic products including tests for COVID-19, G6PD deficiency, dengue fever, influenza, and strep A

Strengthen quality control and customer relationships
Maintain stringent quality control; strengthen relationships with customers including international agencies, non-profit organizations, and retailers.

Develop value-added products
Build a portfolio of value-added products based on cutting-edge technologies in in vitro diagnostics.

Enhance sustainability of profits
Reduce costs via product diversification, economies of scale, and production automation.
CEO MESSAGE
Each and every
life is precious
A healthy life, free of illness, is a long-held wish in society. Guided by the basic principles of cherishing life and health for all people, Access Bio has been dedicated to the research, development and quality improvement of the medical diagnosis industry. Through the development of in vitro diagnostics technology, Access Bio has successfully commercialized products of outstanding quality to battle malaria and other diseases that pose a serious health threat across the globe.
Since our inception in 2002, we have built a strong presence in the global market for the diagnostic testing of malaria and instilled hope for a healthy life among those suffering from this deadly disease.
Quality acknowledged by the WHO
In accordance with the World Health Organization’s global fight against malaria, demand is steadily growing for high-quality rapid diagnostics tests (RDT) for prompt and accurate diagnosis. The superior quality of Access Bio’s CareStart™ has been verified through the malaria diagnostics kit testing by the U.S. Centers for Disease Control and Prevention upon request from the WHO. This has enabled Access Bio to forge partnerships with international agencies including the WHO, UNICEF, Global Fund, and MSF (Medecins Sans Frontieres, Doctors without Borders). Drawing from our solid footing in malaria diagnosis and accumulated R&D expertise, Access Bio strives to develop diagnostic tests in diverse fields and enhance the well-being and quality of life for people around the world.

Our Work Has Just Begun
As we look toward the future, Access Bio will not merely respond to the changing environment, but move forward with a proactive stance.
With efficient processes and a dynamic culture, we will harness our competitive advantage to develop next-generation technologies and sustain growth. As a world leader in medical diagnosis, Access Bio is committed in promoting hope for a healthy life and garnering the trust of all stakeholders.
Thank you.
Young H. Choi – Chairman & CEO
CEO MESSAGE
Each and every
life is precious
A healthy life, free of illness, is a long-held wish in society. Guided by the basic principles of cherishing life and health for all people, Access Bio has been dedicated to the research, development and quality improvement of the medical diagnosis industry. Through the development of in vitro diagnostics technology, Access Bio has successfully commercialized products of outstanding quality to battle malaria and other diseases that pose a serious health threat across the globe.
Since our inception in 2002, we have built a strong presence in the global market for the diagnostic testing of malaria and instilled hope for a healthy life among those suffering from this deadly disease.
Quality acknowledged by the WHO
In accordance with the World Health Organization’s global fight against malaria, demand is steadily growing for high-quality rapid diagnostics tests (RDT) for prompt and accurate diagnosis. The superior quality of Access Bio’s CareStart™has been verified through the malaria diagnostics kit testing by the U.S. Centers for Disease Control and Prevention upon request from the WHO. This has enabled Access Bio to forge partnerships with international agencies including the WHO, UNICEF, Global Fund, and MSF (Medecins Sans Frontieres, Doctors without Borders). Drawing from our solid footing in malaria diagnosis and accumulated R&D expertise, Access Bio strives to develop diagnostic tests in diverse fields and enhance the wellbeing and quality of life for people around the world.

Our Work Has Just Begun
As we look toward the future, Access Bio will not merely respond to the changing environment, but move forward with a proactive stance.
With efficient processes and a dynamic culture, we will harness our competitive advantage to develop next-generation technologies and sustain growth. As a world leader in medical diagnosis, Access Bio is committed in promoting hope for a healthy life and garnering the trust of all stakeholders.
Thank you.
Young H. Choi – Chairman & CEO

Access Bio News
Stay Up to Date with
Access Bio News and
Events
Read about our new product releases and events, and learn more about how Access Bio products are helping to fight disease all over the world.
Learn more
Stay up to date
Sign up to keep being notified about the latest Access Bio news.
Access Bio News
Stay Up to Date with Access Bio News and Events
Read about our new product releases and events, and learn more about how Access Bio products are helping to fight disease all over the world.
Learn more



Stay up to date
Sign up to keep being notified about the latest Access Bio news.